IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 28 filers reported holding IMMUCELL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $159,960 | +2.6% | 31,000 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $155,930 | -2.3% | 31,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $159,650 | -15.8% | 31,000 | 0.0% | 0.01% | -20.0% |
| Q4 2022 | $189,720 | -18.2% | 31,000 | 0.0% | 0.02% | -25.0% |
| Q3 2022 | $232,000 | -13.8% | 31,000 | 0.0% | 0.02% | -13.0% |
| Q2 2022 | $269,000 | -10.0% | 31,000 | 0.0% | 0.02% | 0.0% |
| Q1 2022 | $299,000 | +24.6% | 31,000 | +3.2% | 0.02% | +27.8% |
| Q4 2021 | $240,000 | -13.4% | 30,028 | 0.0% | 0.02% | -18.2% |
| Q3 2021 | $277,000 | -2.8% | 30,028 | 0.0% | 0.02% | -4.3% |
| Q2 2021 | $285,000 | -1.4% | 30,028 | 0.0% | 0.02% | -4.2% |
| Q1 2021 | $289,000 | +61.5% | 30,028 | 0.0% | 0.02% | +50.0% |
| Q4 2020 | $179,000 | +9.8% | 30,028 | 0.0% | 0.02% | -5.9% |
| Q3 2020 | $163,000 | +15.6% | 30,028 | 0.0% | 0.02% | +6.2% |
| Q2 2020 | $141,000 | +23.7% | 30,028 | 0.0% | 0.02% | +6.7% |
| Q1 2020 | $114,000 | -20.8% | 30,028 | +7.1% | 0.02% | -11.8% |
| Q4 2019 | $144,000 | – | 28,028 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Financial Services, Inc. | 23,776 | $89,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 51,263 | $192,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 254 | $1,000 | 0.00% |
| Creative Planning | 310 | $1,000 | 0.00% |
| Renaissance Technologies | 10,000 | $38,000 | 0.00% |
| UBS AG | 1,870 | $7,000 | 0.00% |
| US BANCORP \DE\ | 24 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,032 | $8,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1 | $0 | 0.00% |
| MORGAN STANLEY | 29,628 | $111,000 | 0.00% |